XOMA Royalty (XOMA) Other financing activities (2015 - 2024)

XOMA Royalty's (XOMA) quarterly Other financing activities came in at $79000.0 in Q3 2024, down 1.25% quarter-over-quarter from $80000.0 in Q2 2024.

XOMA Royalty (XOMA) Other financing activities (2015 - 2024) Analysis & Trends

XOMA Royalty has disclosed Other financing activities across 8 years of filings, most recently posting $79000.0 for Q3 2024.

  • Other financing activities for Q3 2024 came in at $79000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $159000.0 (down 81.58% YoY), and the FY2024 annual result was $740000.0, down 82.6% from the prior year.
  • Other financing activities came in at $79000.0 for Q3 2024 at XOMA Royalty, down from $80000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.0 million in Q2 2021 to a low of $20000.0 in Q3 2020.
  • The 5-year median for Other financing activities is $123000.0 (2020), against an average of $482923.1.
  • Peak annual rise in Other financing activities reached 2352.03% in 2021, while the deepest fall reached 92.01% in 2021.
  • XOMA Royalty's Other financing activities stood at $1.7 million in 2020, then plunged by 92.01% to $137000.0 in 2021, then tumbled by 37.96% to $85000.0 in 2022, then jumped by 44.71% to $123000.0 in 2023, then sank by 35.77% to $79000.0 in 2024.
  • The last three Other financing activities figures came in at $79000.0 (Q3 2024), $80000.0 (Q2 2024), and $581000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 79,000.00
Sep 30, 2024 79,000.00
Jun 30, 2024 80,000.00
Jun 30, 2024 80,000.00
Mar 31, 2024 581,000.00
Mar 31, 2024 581,000.00
Mar 31, 2023 123,000.00
Mar 31, 2023 123,000.00
Mar 31, 2022 85,000.00
Mar 31, 2022 85,000.00
Dec 31, 2021 137,000.00
Dec 31, 2021 137,000.00
Sep 30, 2021 142,000.00
Sep 30, 2021 142,000.00
Jun 30, 2021 3.02 Mn
Jun 30, 2021 3.02 Mn
Mar 31, 2021 90,000.00
Mar 31, 2021 90,000.00
Dec 31, 2020 1.71 Mn
Dec 31, 2020 1.71 Mn